Today on the CLL Society website, we share a continuation of the Targeted Therapies for CLL theme with Dr. Jeffrey Jones speaking about how Kinase Inhibitors work in treating CLL, both those currently available, as well as new second generation kinase inhibitors and next steps to fully understanding the best use of these targeted agents. He spoke at the Patient Empowerment and Education Meeting held at UCSD in April 2015. Please take a look here to see the article and a video of his talk.
By the time you read this, I will have completed my family practice board exams and all eyes will look forward to Thanksgiving with the family and then on to the American Society of Hematology Annual Meeting in Orlando. No rest for the weary! We’re now putting the final tweaks on our schedule to attend the most exciting presentations about CLL, viewing the CLL posters and interviewing CLL experts from around the world. These are very exciting times for patients and those researching the most effective treatments for CLL in the goal towards a cure.
REGISTER NOW: If you live in the Los Angeles area, please consider attending a post-ASH patient education forum and CLL Society LA support group launch in conjunction with City of Hope. Dr. Tanya Siddiqi will be presenting on the latest data on Diagnosis and Frontline Treatment and Dr. Steven Rosen will present on Relapsed Disease and Novel Therapies. The meeting is scheduled for Saturday, Dec. 12, 2015. You can access the flyer here and pre-registration is requested. We look forward to meeting you there.
Finally, if you are receiving this email through a CLL Society Alert, you are all set. If you are receiving this through another method and haven’t already, please sign up here. Also, please forward this email to a fellow patient or caregiver who might benefit from knowing more about CLL. Leading up to ASH, we will be posting a backlog of great lectures and interviews and articles on CLL. This alert is your best friend in knowing what new material we have posted.
We are all this together
Volunteer Medical Director of the CLL Society